In the treatment of many advanced cancers, molecular profiling for the detection of tumor mutations and genomic signatures is recognized as the standard of care.
Archive | Of Interest
New Intralesional Therapy Combinations Are Poised to Expand Beyond the Oncology Setting
Posted in Melanoma News, Health Professionals, Of Interest
Scientists identify new target for melanoma immunotherapy
QIMR Berghofer research has found a new reason why some melanoma patients do not respond well to immunotherapy—a discovery that could lead to better-tailored treatments for the potentially deadly cancer.
Posted in Melanoma News, Health Professionals, Of Interest
Research finds why immunotherapy fails some melanoma patients
Researchers have discovered why certain people with melanoma do not respond to immunotherapy, with hopes the discovery will lead to better treatments for people with the deadly cancer.
Posted in Melanoma News, Health Professionals, Of Interest
Wearable patch may provide new treatment option for skin cancer
WEST LAFAYETTE, Ind. – Conventional melanoma therapies, including chemotherapy and radiotherapy, suffer from the toxicity and side effects of repeated treatments due to the aggressive and recurrent nature of melanoma cells.
Posted in Melanoma News, Health Professionals, Of Interest
